Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Department of Geriatrics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Crit Rev Food Sci Nutr. 2024;64(17):5852-5877. doi: 10.1080/10408398.2022.2159317. Epub 2023 Jan 2.
Diabetes mellitus (DM) is a global health issue in the twenty-first century, and there are numerous challenges in preventing and alleviating its chronic complications. The herb has beneficial therapeutic effects on various human diseases, including DM. Its major flavonoid component, icariin, has significant anti-DM activity and may help improve pancreatic β-cell dysfunction and insulin resistance. Furthermore, preclinical evidence has shown that icariin and its in vivo bioactive form, icariside II, have preventive and therapeutic effects on several diabetic complications, including diabetic cardiomyopathy, diabetic vascular endothelial disorder, diabetic nephropathy, and diabetic erectile dysfunction. In this review, we present the general and toxicological information concerning icariin and icariside II and review the anti-DM effects of icariin from a molecular perspective. Additionally, we discuss the potential benefits of icariin and icariside II on the important pathological mechanisms of various diabetic complications. Despite positive preclinical evidence, additional investigations are needed before relevant clinical studies can be conducted. Therefore, we conclude with suggestions for future research. Hopefully, this review will provide a comprehensive molecular perspective for future research and product development related to icariin and icariside II in treating DM and diabetic complications.
糖尿病(DM)是 21 世纪的全球性健康问题,在预防和缓解其慢性并发症方面存在诸多挑战。该草药对包括 DM 在内的多种人类疾病具有有益的治疗作用。其主要的黄酮类成分淫羊藿苷具有显著的抗 DM 活性,可能有助于改善胰岛β细胞功能障碍和胰岛素抵抗。此外,临床前证据表明,淫羊藿苷及其体内生物活性形式淫羊藿次苷 II 对几种糖尿病并发症具有预防和治疗作用,包括糖尿病性心肌病、糖尿病血管内皮功能障碍、糖尿病肾病和糖尿病性勃起功能障碍。在这篇综述中,我们介绍了淫羊藿苷和淫羊藿次苷 II 的一般和毒理学信息,并从分子角度综述了淫羊藿苷的抗 DM 作用。此外,我们还讨论了淫羊藿苷和淫羊藿次苷 II 对各种糖尿病并发症重要病理机制的潜在益处。尽管有积极的临床前证据,但在进行相关的临床研究之前,还需要进一步的研究。因此,我们为未来的研究提出了建议。希望本综述能为淫羊藿苷和淫羊藿次苷 II 治疗 DM 和糖尿病并发症的未来研究和产品开发提供全面的分子视角。